nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—Mesalazine—Crohn's disease	0.345	1	CrCtD
Diflunisal—osteoarthritis—Prednisone—Crohn's disease	0.15	1	CpDpCtD
Diflunisal—Olsalazine—Balsalazide—Crohn's disease	0.062	0.275	CrCrCtD
Diflunisal—PTGS2—Crohn's disease	0.0588	0.529	CbGaD
Diflunisal—ALB—Crohn's disease	0.0524	0.471	CbGaD
Diflunisal—Olsalazine—Mesalazine—Crohn's disease	0.0486	0.216	CrCrCtD
Diflunisal—Olsalazine—Sulfasalazine—Crohn's disease	0.047	0.209	CrCrCtD
Diflunisal—Aminosalicylic Acid—Mesalazine—Crohn's disease	0.043	0.191	CrCrCtD
Diflunisal—PTGS2—Balsalazide—Crohn's disease	0.0339	0.229	CbGbCtD
Diflunisal—PTGS1—Balsalazide—Crohn's disease	0.0287	0.193	CbGbCtD
Diflunisal—PTGS2—Mesalazine—Crohn's disease	0.0271	0.183	CbGbCtD
Diflunisal—Salicylic acid—Mesalazine—Crohn's disease	0.0247	0.11	CrCrCtD
Diflunisal—PTGS1—Mesalazine—Crohn's disease	0.0229	0.155	CbGbCtD
Diflunisal—PTGS2—Sulfasalazine—Crohn's disease	0.0152	0.102	CbGbCtD
Diflunisal—PTGS1—Sulfasalazine—Crohn's disease	0.0128	0.0863	CbGbCtD
Diflunisal—ALB—Prednisone—Crohn's disease	0.00764	0.0515	CbGbCtD
Diflunisal—UGT1A8—mouth—Crohn's disease	0.00117	0.283	CbGeAlD
Diflunisal—Niclosamide—STAT3—Crohn's disease	0.000655	0.4	CrCbGaD
Diflunisal—UGT1A8—digestive system—Crohn's disease	0.000519	0.125	CbGeAlD
Diflunisal—Cholestasis—Mercaptopurine—Crohn's disease	0.00042	0.0423	CcSEcCtD
Diflunisal—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.000399	0.075	CbGpPWpGaD
Diflunisal—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.000399	0.075	CbGpPWpGaD
Diflunisal—ALB—gall bladder—Crohn's disease	0.000386	0.0933	CbGeAlD
Diflunisal—Nephrotic syndrome—Mesalazine—Crohn's disease	0.000358	0.0361	CcSEcCtD
Diflunisal—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX4—Crohn's disease	0.000347	0.0653	CbGpPWpGaD
Diflunisal—Olsalazine—IFNG—Crohn's disease	0.000332	0.203	CrCbGaD
Diflunisal—Nephritis interstitial—Mesalazine—Crohn's disease	0.000256	0.0258	CcSEcCtD
Diflunisal—Cholestasis—Azathioprine—Crohn's disease	0.00025	0.0252	CcSEcCtD
Diflunisal—TTR—lymphoid tissue—Crohn's disease	0.000241	0.0583	CbGeAlD
Diflunisal—TTR—digestive system—Crohn's disease	0.000238	0.0575	CbGeAlD
Diflunisal—Cholestasis—Mesalazine—Crohn's disease	0.000228	0.023	CcSEcCtD
Diflunisal—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.000226	0.0228	CcSEcCtD
Diflunisal—PTGS2—gall bladder—Crohn's disease	0.00021	0.0508	CbGeAlD
Diflunisal—Proteinuria—Mesalazine—Crohn's disease	0.000197	0.0198	CcSEcCtD
Diflunisal—Protein urine present—Mesalazine—Crohn's disease	0.000194	0.0196	CcSEcCtD
Diflunisal—PTGS2—mouth—Crohn's disease	0.000187	0.0452	CbGeAlD
Diflunisal—TTR—Amyloids—LTF—Crohn's disease	0.000178	0.0335	CbGpPWpGaD
Diflunisal—Stomatitis—Mercaptopurine—Crohn's disease	0.000174	0.0175	CcSEcCtD
Diflunisal—Eructation—Mesalazine—Crohn's disease	0.00017	0.0171	CcSEcCtD
Diflunisal—Aminosalicylic Acid—MPO—Crohn's disease	0.000166	0.101	CrCbGaD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—CREM—Crohn's disease	0.000159	0.0298	CbGpPWpGaD
Diflunisal—Photosensitivity—Mesalazine—Crohn's disease	0.000143	0.0144	CcSEcCtD
Diflunisal—Deafness—Mesalazine—Crohn's disease	0.00014	0.0141	CcSEcCtD
Diflunisal—Disorientation—Mesalazine—Crohn's disease	0.00014	0.0141	CcSEcCtD
Diflunisal—Peptic ulcer—Prednisone—Crohn's disease	0.000137	0.0138	CcSEcCtD
Diflunisal—Renal impairment—Mesalazine—Crohn's disease	0.000132	0.0133	CcSEcCtD
Diflunisal—Mesalazine—MPO—Crohn's disease	0.00013	0.0793	CrCbGaD
Diflunisal—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000126	0.0127	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000124	0.0125	CcSEcCtD
Diflunisal—PTGS1—epithelium—Crohn's disease	0.000114	0.0275	CbGeAlD
Diflunisal—Oedema—Mercaptopurine—Crohn's disease	0.000114	0.0115	CcSEcCtD
Diflunisal—Cramp muscle—Mesalazine—Crohn's disease	0.000113	0.0114	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	0.000112	0.0211	CbGpPWpGaD
Diflunisal—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000111	0.0112	CcSEcCtD
Diflunisal—Gastritis—Mesalazine—Crohn's disease	0.000111	0.0112	CcSEcCtD
Diflunisal—PTGS1—smooth muscle tissue—Crohn's disease	0.00011	0.0265	CbGeAlD
Diflunisal—PTGS2—epithelium—Crohn's disease	0.000109	0.0263	CbGeAlD
Diflunisal—Anorexia—Mercaptopurine—Crohn's disease	0.000108	0.0109	CcSEcCtD
Diflunisal—PTGS1—skin of body—Crohn's disease	0.000108	0.0262	CbGeAlD
Diflunisal—Bronchospasm—Mesalazine—Crohn's disease	0.000107	0.0108	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—MADCAM1—Crohn's disease	0.000106	0.02	CbGpPWpGaD
Diflunisal—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000105	0.0106	CcSEcCtD
Diflunisal—PTGS2—smooth muscle tissue—Crohn's disease	0.000105	0.0253	CbGeAlD
Diflunisal—PTGS2—skin of body—Crohn's disease	0.000104	0.025	CbGeAlD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	0.000103	0.0193	CbGpPWpGaD
Diflunisal—Dysuria—Mesalazine—Crohn's disease	0.000102	0.0102	CcSEcCtD
Diflunisal—Agranulocytosis—Azathioprine—Crohn's disease	9.92e-05	0.00999	CcSEcCtD
Diflunisal—Photosensitivity reaction—Mesalazine—Crohn's disease	9.91e-05	0.00998	CcSEcCtD
Diflunisal—Decreased appetite—Mercaptopurine—Crohn's disease	9.89e-05	0.00996	CcSEcCtD
Diflunisal—PTGS1—mammalian vulva—Crohn's disease	9.88e-05	0.0239	CbGeAlD
Diflunisal—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	9.6e-05	0.00967	CcSEcCtD
Diflunisal—Renal failure—Mesalazine—Crohn's disease	9.52e-05	0.00959	CcSEcCtD
Diflunisal—Stomatitis—Mesalazine—Crohn's disease	9.44e-05	0.00951	CcSEcCtD
Diflunisal—Jaundice—Mesalazine—Crohn's disease	9.44e-05	0.00951	CcSEcCtD
Diflunisal—Sweating—Mesalazine—Crohn's disease	9.28e-05	0.00935	CcSEcCtD
Diflunisal—Haematuria—Mesalazine—Crohn's disease	9.23e-05	0.0093	CcSEcCtD
Diflunisal—Agranulocytosis—Mesalazine—Crohn's disease	9.03e-05	0.0091	CcSEcCtD
Diflunisal—Erythema multiforme—Azathioprine—Crohn's disease	9.02e-05	0.00909	CcSEcCtD
Diflunisal—Body temperature increased—Mercaptopurine—Crohn's disease	8.99e-05	0.00906	CcSEcCtD
Diflunisal—Hepatitis—Mesalazine—Crohn's disease	8.69e-05	0.00875	CcSEcCtD
Diflunisal—ALB—lymph node—Crohn's disease	8.68e-05	0.021	CbGeAlD
Diflunisal—PTGS1—digestive system—Crohn's disease	8.66e-05	0.0209	CbGeAlD
Diflunisal—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	8.6e-05	0.0162	CbGpPWpGaD
Diflunisal—PTGS2—lymphoid tissue—Crohn's disease	8.38e-05	0.0203	CbGeAlD
Diflunisal—Hypersensitivity—Mercaptopurine—Crohn's disease	8.38e-05	0.00844	CcSEcCtD
Diflunisal—PTGS2—digestive system—Crohn's disease	8.28e-05	0.02	CbGeAlD
Diflunisal—Erythema multiforme—Mesalazine—Crohn's disease	8.22e-05	0.00828	CcSEcCtD
Diflunisal—Tinnitus—Mesalazine—Crohn's disease	8.1e-05	0.00816	CcSEcCtD
Diflunisal—PTGS1—Arachidonic acid metabolism—GPX4—Crohn's disease	8.02e-05	0.0151	CbGpPWpGaD
Diflunisal—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	8e-05	0.015	CbGpPWpGaD
Diflunisal—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	8e-05	0.015	CbGpPWpGaD
Diflunisal—Diarrhoea—Mercaptopurine—Crohn's disease	7.78e-05	0.00784	CcSEcCtD
Diflunisal—Flatulence—Mesalazine—Crohn's disease	7.45e-05	0.00751	CcSEcCtD
Diflunisal—Tension—Mesalazine—Crohn's disease	7.42e-05	0.00748	CcSEcCtD
Diflunisal—TTR—FOXA2 and FOXA3 transcription factor networks—ALB—Crohn's disease	7.38e-05	0.0139	CbGpPWpGaD
Diflunisal—Nervousness—Mesalazine—Crohn's disease	7.35e-05	0.0074	CcSEcCtD
Diflunisal—Muscle spasms—Mesalazine—Crohn's disease	7.27e-05	0.00733	CcSEcCtD
Diflunisal—Vomiting—Mercaptopurine—Crohn's disease	7.23e-05	0.00729	CcSEcCtD
Diflunisal—Rash—Mercaptopurine—Crohn's disease	7.17e-05	0.00723	CcSEcCtD
Diflunisal—Dermatitis—Mercaptopurine—Crohn's disease	7.17e-05	0.00722	CcSEcCtD
Diflunisal—Vision blurred—Mesalazine—Crohn's disease	7.13e-05	0.00718	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—CRP—Crohn's disease	6.98e-05	0.0131	CbGpPWpGaD
Diflunisal—Angioedema—Mesalazine—Crohn's disease	6.91e-05	0.00696	CcSEcCtD
Diflunisal—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	6.83e-05	0.0128	CbGpPWpGaD
Diflunisal—Vertigo—Mesalazine—Crohn's disease	6.8e-05	0.00685	CcSEcCtD
Diflunisal—Syncope—Mesalazine—Crohn's disease	6.78e-05	0.00683	CcSEcCtD
Diflunisal—Nausea—Mercaptopurine—Crohn's disease	6.76e-05	0.00681	CcSEcCtD
Diflunisal—Palpitations—Mesalazine—Crohn's disease	6.69e-05	0.00673	CcSEcCtD
Diflunisal—Loss of consciousness—Mesalazine—Crohn's disease	6.65e-05	0.0067	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	6.65e-05	0.0067	CcSEcCtD
Diflunisal—Thrombocytopenia—Azathioprine—Crohn's disease	6.64e-05	0.00669	CcSEcCtD
Diflunisal—Olsalazine—PTGS2—Crohn's disease	6.6e-05	0.0403	CrCbGaD
Diflunisal—Chest pain—Mesalazine—Crohn's disease	6.44e-05	0.00649	CcSEcCtD
Diflunisal—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	6.37e-05	0.012	CbGpPWpGaD
Diflunisal—Confusional state—Mesalazine—Crohn's disease	6.23e-05	0.00627	CcSEcCtD
Diflunisal—Aminosalicylic Acid—PTGS2—Crohn's disease	6.2e-05	0.0379	CrCbGaD
Diflunisal—Oedema—Mesalazine—Crohn's disease	6.17e-05	0.00622	CcSEcCtD
Diflunisal—Anaphylactic shock—Mesalazine—Crohn's disease	6.17e-05	0.00622	CcSEcCtD
Diflunisal—Shock—Mesalazine—Crohn's disease	6.07e-05	0.00612	CcSEcCtD
Diflunisal—Thrombocytopenia—Mesalazine—Crohn's disease	6.05e-05	0.00609	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	5.98e-05	0.0112	CbGpPWpGaD
Diflunisal—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	5.97e-05	0.0112	CbGpPWpGaD
Diflunisal—Hyperhidrosis—Mesalazine—Crohn's disease	5.97e-05	0.00601	CcSEcCtD
Diflunisal—Anorexia—Mesalazine—Crohn's disease	5.89e-05	0.00593	CcSEcCtD
Diflunisal—Salsalate—PTGS2—Crohn's disease	5.61e-05	0.0343	CrCbGaD
Diflunisal—Feeling abnormal—Azathioprine—Crohn's disease	5.59e-05	0.00563	CcSEcCtD
Diflunisal—Insomnia—Mesalazine—Crohn's disease	5.58e-05	0.00563	CcSEcCtD
Diflunisal—Paraesthesia—Mesalazine—Crohn's disease	5.54e-05	0.00558	CcSEcCtD
Diflunisal—Gastrointestinal pain—Azathioprine—Crohn's disease	5.54e-05	0.00558	CcSEcCtD
Diflunisal—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	5.54e-05	0.0104	CbGpPWpGaD
Diflunisal—Dyspnoea—Mesalazine—Crohn's disease	5.5e-05	0.00554	CcSEcCtD
Diflunisal—Somnolence—Mesalazine—Crohn's disease	5.49e-05	0.00553	CcSEcCtD
Diflunisal—Dyspepsia—Mesalazine—Crohn's disease	5.43e-05	0.00547	CcSEcCtD
Diflunisal—Decreased appetite—Mesalazine—Crohn's disease	5.37e-05	0.00541	CcSEcCtD
Diflunisal—Body temperature increased—Azathioprine—Crohn's disease	5.36e-05	0.0054	CcSEcCtD
Diflunisal—Fatigue—Mesalazine—Crohn's disease	5.32e-05	0.00536	CcSEcCtD
Diflunisal—Constipation—Mesalazine—Crohn's disease	5.28e-05	0.00532	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	5.1e-05	0.00959	CbGpPWpGaD
Diflunisal—Feeling abnormal—Mesalazine—Crohn's disease	5.09e-05	0.00513	CcSEcCtD
Diflunisal—Gastrointestinal pain—Mesalazine—Crohn's disease	5.05e-05	0.00509	CcSEcCtD
Diflunisal—Hypersensitivity—Azathioprine—Crohn's disease	4.99e-05	0.00503	CcSEcCtD
Diflunisal—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	4.98e-05	0.00936	CbGpPWpGaD
Diflunisal—PTGS1—lymph node—Crohn's disease	4.95e-05	0.012	CbGeAlD
Diflunisal—Urticaria—Mesalazine—Crohn's disease	4.9e-05	0.00494	CcSEcCtD
Diflunisal—Body temperature increased—Mesalazine—Crohn's disease	4.88e-05	0.00492	CcSEcCtD
Diflunisal—Mesalazine—PTGS2—Crohn's disease	4.87e-05	0.0297	CrCbGaD
Diflunisal—PTGS2—lymph node—Crohn's disease	4.73e-05	0.0114	CbGeAlD
Diflunisal—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	4.68e-05	0.00879	CbGpPWpGaD
Diflunisal—Diarrhoea—Azathioprine—Crohn's disease	4.64e-05	0.00467	CcSEcCtD
Diflunisal—Hallucination—Prednisone—Crohn's disease	4.58e-05	0.00461	CcSEcCtD
Diflunisal—Hypersensitivity—Mesalazine—Crohn's disease	4.55e-05	0.00458	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	4.54e-05	0.00853	CbGpPWpGaD
Diflunisal—Dizziness—Azathioprine—Crohn's disease	4.48e-05	0.00452	CcSEcCtD
Diflunisal—Asthenia—Mesalazine—Crohn's disease	4.43e-05	0.00446	CcSEcCtD
Diflunisal—Pruritus—Mesalazine—Crohn's disease	4.37e-05	0.0044	CcSEcCtD
Diflunisal—Vomiting—Azathioprine—Crohn's disease	4.31e-05	0.00434	CcSEcCtD
Diflunisal—Rash—Azathioprine—Crohn's disease	4.27e-05	0.00431	CcSEcCtD
Diflunisal—Dermatitis—Azathioprine—Crohn's disease	4.27e-05	0.0043	CcSEcCtD
Diflunisal—Flushing—Prednisone—Crohn's disease	4.27e-05	0.0043	CcSEcCtD
Diflunisal—Headache—Azathioprine—Crohn's disease	4.25e-05	0.00428	CcSEcCtD
Diflunisal—Diarrhoea—Mesalazine—Crohn's disease	4.22e-05	0.00426	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	4.19e-05	0.00787	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—GPX4—Crohn's disease	4.13e-05	0.00775	CbGpPWpGaD
Diflunisal—Dizziness—Mesalazine—Crohn's disease	4.08e-05	0.00411	CcSEcCtD
Diflunisal—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	4.05e-05	0.00761	CbGpPWpGaD
Diflunisal—Nausea—Azathioprine—Crohn's disease	4.03e-05	0.00406	CcSEcCtD
Diflunisal—Vomiting—Mesalazine—Crohn's disease	3.93e-05	0.00395	CcSEcCtD
Diflunisal—Rash—Mesalazine—Crohn's disease	3.89e-05	0.00392	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	3.89e-05	0.00731	CbGpPWpGaD
Diflunisal—Dermatitis—Mesalazine—Crohn's disease	3.89e-05	0.00392	CcSEcCtD
Diflunisal—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	3.88e-05	0.00729	CbGpPWpGaD
Diflunisal—Headache—Mesalazine—Crohn's disease	3.87e-05	0.0039	CcSEcCtD
Diflunisal—ALB—Vitamin B12 Metabolism—MPO—Crohn's disease	3.87e-05	0.00727	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	3.87e-05	0.00726	CbGpPWpGaD
Diflunisal—Vision blurred—Prednisone—Crohn's disease	3.77e-05	0.0038	CcSEcCtD
Diflunisal—Nausea—Mesalazine—Crohn's disease	3.67e-05	0.00369	CcSEcCtD
Diflunisal—Angioedema—Prednisone—Crohn's disease	3.66e-05	0.00368	CcSEcCtD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	3.63e-05	0.00683	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	3.63e-05	0.00683	CbGpPWpGaD
Diflunisal—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	3.6e-05	0.00677	CbGpPWpGaD
Diflunisal—Vertigo—Prednisone—Crohn's disease	3.6e-05	0.00362	CcSEcCtD
Diflunisal—Syncope—Prednisone—Crohn's disease	3.59e-05	0.00362	CcSEcCtD
Diflunisal—ALB—Platelet degranulation—F5—Crohn's disease	3.58e-05	0.00673	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—ITGA4—Crohn's disease	3.56e-05	0.0067	CbGpPWpGaD
Diflunisal—Loss of consciousness—Prednisone—Crohn's disease	3.52e-05	0.00354	CcSEcCtD
Diflunisal—Salicylic acid—PTGS2—Crohn's disease	3.45e-05	0.0211	CrCbGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	3.41e-05	0.00641	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—GPX4—Crohn's disease	3.28e-05	0.00616	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	3.27e-05	0.00614	CbGpPWpGaD
Diflunisal—Oedema—Prednisone—Crohn's disease	3.27e-05	0.00329	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisone—Crohn's disease	3.27e-05	0.00329	CcSEcCtD
Diflunisal—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	3.25e-05	0.0061	CbGpPWpGaD
Diflunisal—Shock—Prednisone—Crohn's disease	3.21e-05	0.00324	CcSEcCtD
Diflunisal—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	3.21e-05	0.00603	CbGpPWpGaD
Diflunisal—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	3.16e-05	0.00594	CbGpPWpGaD
Diflunisal—Hyperhidrosis—Prednisone—Crohn's disease	3.16e-05	0.00318	CcSEcCtD
Diflunisal—ALB—Folate Metabolism—MPO—Crohn's disease	3.15e-05	0.00591	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PLA2G4F—Crohn's disease	3.12e-05	0.00587	CbGpPWpGaD
Diflunisal—Anorexia—Prednisone—Crohn's disease	3.11e-05	0.00314	CcSEcCtD
Diflunisal—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	3.09e-05	0.00581	CbGpPWpGaD
Diflunisal—Salicylic acid—ALB—Crohn's disease	3.08e-05	0.0188	CrCbGaD
Diflunisal—Flurbiprofen—PTGS2—Crohn's disease	3.03e-05	0.0185	CrCbGaD
Diflunisal—Insomnia—Prednisone—Crohn's disease	2.95e-05	0.00298	CcSEcCtD
Diflunisal—Paraesthesia—Prednisone—Crohn's disease	2.93e-05	0.00295	CcSEcCtD
Diflunisal—Dyspepsia—Prednisone—Crohn's disease	2.88e-05	0.0029	CcSEcCtD
Diflunisal—Decreased appetite—Prednisone—Crohn's disease	2.84e-05	0.00286	CcSEcCtD
Diflunisal—Fatigue—Prednisone—Crohn's disease	2.82e-05	0.00284	CcSEcCtD
Diflunisal—Constipation—Prednisone—Crohn's disease	2.79e-05	0.00281	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	2.76e-05	0.00519	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	2.71e-05	0.00509	CbGpPWpGaD
Diflunisal—Flurbiprofen—ALB—Crohn's disease	2.7e-05	0.0165	CrCbGaD
Diflunisal—Feeling abnormal—Prednisone—Crohn's disease	2.69e-05	0.00271	CcSEcCtD
Diflunisal—Gastrointestinal pain—Prednisone—Crohn's disease	2.67e-05	0.00269	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—MTMR3—Crohn's disease	2.65e-05	0.00499	CbGpPWpGaD
Diflunisal—Urticaria—Prednisone—Crohn's disease	2.6e-05	0.00261	CcSEcCtD
Diflunisal—Body temperature increased—Prednisone—Crohn's disease	2.58e-05	0.0026	CcSEcCtD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	2.56e-05	0.00481	CbGpPWpGaD
Diflunisal—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	2.55e-05	0.00479	CbGpPWpGaD
Diflunisal—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	2.51e-05	0.00471	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	2.5e-05	0.0047	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	2.42e-05	0.00454	CbGpPWpGaD
Diflunisal—Hypersensitivity—Prednisone—Crohn's disease	2.41e-05	0.00242	CcSEcCtD
Diflunisal—Asthenia—Prednisone—Crohn's disease	2.34e-05	0.00236	CcSEcCtD
Diflunisal—TTR—Disease—RSPO3—Crohn's disease	2.32e-05	0.00436	CbGpPWpGaD
Diflunisal—Pruritus—Prednisone—Crohn's disease	2.31e-05	0.00233	CcSEcCtD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	2.26e-05	0.00425	CbGpPWpGaD
Diflunisal—Diarrhoea—Prednisone—Crohn's disease	2.24e-05	0.00225	CcSEcCtD
Diflunisal—TTR—Disease—SEL1L—Crohn's disease	2.2e-05	0.00414	CbGpPWpGaD
Diflunisal—Dizziness—Prednisone—Crohn's disease	2.16e-05	0.00218	CcSEcCtD
Diflunisal—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.16e-05	0.00405	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ACKR2—Crohn's disease	2.15e-05	0.00403	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—ICAM1—Crohn's disease	2.11e-05	0.00397	CbGpPWpGaD
Diflunisal—Vomiting—Prednisone—Crohn's disease	2.08e-05	0.00209	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—FADS1—Crohn's disease	2.07e-05	0.00389	CbGpPWpGaD
Diflunisal—Rash—Prednisone—Crohn's disease	2.06e-05	0.00207	CcSEcCtD
Diflunisal—Dermatitis—Prednisone—Crohn's disease	2.06e-05	0.00207	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	2.05e-05	0.00385	CbGpPWpGaD
Diflunisal—Headache—Prednisone—Crohn's disease	2.05e-05	0.00206	CcSEcCtD
Diflunisal—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	2.03e-05	0.00382	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MLN—Crohn's disease	2.03e-05	0.00382	CbGpPWpGaD
Diflunisal—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	2.02e-05	0.0038	CbGpPWpGaD
Diflunisal—TTR—Disease—LTF—Crohn's disease	1.97e-05	0.00371	CbGpPWpGaD
Diflunisal—Nausea—Prednisone—Crohn's disease	1.94e-05	0.00195	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—GPX4—Crohn's disease	1.94e-05	0.00364	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	1.89e-05	0.00355	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	1.89e-05	0.00355	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.88e-05	0.00354	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—GCKR—Crohn's disease	1.87e-05	0.00351	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	1.87e-05	0.00351	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TAGAP—Crohn's disease	1.86e-05	0.0035	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.85e-05	0.00347	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.85e-05	0.00347	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.85e-05	0.00347	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	1.79e-05	0.00336	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	1.66e-05	0.00312	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—CRP—Crohn's disease	1.66e-05	0.00311	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RSPO3—Crohn's disease	1.63e-05	0.00306	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	1.63e-05	0.00305	CbGpPWpGaD
Diflunisal—TTR—Disease—GCKR—Crohn's disease	1.59e-05	0.00299	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	1.59e-05	0.00299	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.57e-05	0.00295	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	1.57e-05	0.00295	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SEL1L—Crohn's disease	1.54e-05	0.0029	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—ICAM1—Crohn's disease	1.52e-05	0.00286	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.49e-05	0.00281	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.47e-05	0.00276	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	1.43e-05	0.00269	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	1.42e-05	0.00267	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCR9—Crohn's disease	1.41e-05	0.00265	CbGpPWpGaD
Diflunisal—TTR—Disease—SLC11A1—Crohn's disease	1.41e-05	0.00264	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	1.37e-05	0.00258	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	1.33e-05	0.0025	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	1.32e-05	0.00249	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	1.31e-05	0.00247	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GPR65—Crohn's disease	1.31e-05	0.00246	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.3e-05	0.00244	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	1.28e-05	0.0024	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	1.27e-05	0.00238	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.25e-05	0.00234	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	1.25e-05	0.00234	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.24e-05	0.00232	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	1.23e-05	0.00232	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.22e-05	0.0023	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.21e-05	0.00227	CbGpPWpGaD
Diflunisal—TTR—Disease—RBX1—Crohn's disease	1.21e-05	0.00227	CbGpPWpGaD
Diflunisal—TTR—Disease—HSPA1B—Crohn's disease	1.21e-05	0.00227	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.19e-05	0.00223	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	1.18e-05	0.00222	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	1.18e-05	0.00221	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IFNG—Crohn's disease	1.16e-05	0.00218	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	1.16e-05	0.00217	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.15e-05	0.00216	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.15e-05	0.00215	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	1.14e-05	0.00214	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	1.14e-05	0.00214	CbGpPWpGaD
Diflunisal—TTR—Disease—UBE2D1—Crohn's disease	1.06e-05	0.00199	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL1B—Crohn's disease	1.03e-05	0.00194	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	1.01e-05	0.00191	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.01e-05	0.0019	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	9.72e-06	0.00183	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.6e-06	0.0018	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.6e-06	0.0018	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	9.53e-06	0.00179	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCR6—Crohn's disease	9.34e-06	0.00175	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	9.27e-06	0.00174	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	9.21e-06	0.00173	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	9.21e-06	0.00173	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	9.2e-06	0.00173	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	9.1e-06	0.00171	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	8.99e-06	0.00169	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	8.82e-06	0.00166	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RBX1—Crohn's disease	8.45e-06	0.00159	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	8.36e-06	0.00157	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PLA2G4F—Crohn's disease	8.23e-06	0.00155	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTGER4—Crohn's disease	8.22e-06	0.00154	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	8.2e-06	0.00154	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—F5—Crohn's disease	8.19e-06	0.00154	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	8.15e-06	0.00153	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	8.02e-06	0.00151	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	7.87e-06	0.00148	CbGpPWpGaD
Diflunisal—TTR—Disease—SMAD3—Crohn's disease	7.57e-06	0.00142	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TNF—Crohn's disease	7.49e-06	0.00141	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	7.48e-06	0.00141	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	7.43e-06	0.0014	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—UBE2D1—Crohn's disease	7.41e-06	0.00139	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.36e-06	0.00138	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	7.36e-06	0.00138	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RIPK2—Crohn's disease	7.18e-06	0.00135	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL3—Crohn's disease	7e-06	0.00132	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—MTMR3—Crohn's disease	7e-06	0.00132	CbGpPWpGaD
Diflunisal—PTGS2—Disease—RSPO3—Crohn's disease	6.82e-06	0.00128	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RASGRP1—Crohn's disease	6.77e-06	0.00127	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.76e-06	0.00127	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	6.67e-06	0.00125	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PLA2G4F—Crohn's disease	6.54e-06	0.00123	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SEL1L—Crohn's disease	6.47e-06	0.00122	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SOCS1—Crohn's disease	6.14e-06	0.00115	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL6—Crohn's disease	6.05e-06	0.00114	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.98e-06	0.00112	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ALB—Crohn's disease	5.95e-06	0.00112	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	5.95e-06	0.00112	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	5.94e-06	0.00112	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	5.82e-06	0.00109	CbGpPWpGaD
Diflunisal—PTGS2—Disease—LTF—Crohn's disease	5.8e-06	0.00109	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—MTMR3—Crohn's disease	5.56e-06	0.00104	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—FADS1—Crohn's disease	5.45e-06	0.00102	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SMAD3—Crohn's disease	5.3e-06	0.000995	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PLA2G4F—Crohn's disease	5.29e-06	0.000994	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTGS2—Crohn's disease	5.21e-06	0.000979	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GPX4—Crohn's disease	5.11e-06	0.00096	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ITGA4—Crohn's disease	5.03e-06	0.000946	CbGpPWpGaD
Diflunisal—TTR—Disease—TYK2—Crohn's disease	4.94e-06	0.000927	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GCKR—Crohn's disease	4.93e-06	0.000927	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL3—Crohn's disease	4.91e-06	0.000923	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2RA—Crohn's disease	4.91e-06	0.000922	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	4.8e-06	0.000903	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—RASGRP1—Crohn's disease	4.75e-06	0.000892	CbGpPWpGaD
Diflunisal—TTR—Disease—JAK2—Crohn's disease	4.71e-06	0.000885	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	4.69e-06	0.000882	CbGpPWpGaD
Diflunisal—PTGS2—Disease—GCKR—Crohn's disease	4.68e-06	0.000879	CbGpPWpGaD
Diflunisal—ALB—Metabolism—MTMR3—Crohn's disease	4.5e-06	0.000845	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	4.48e-06	0.000843	CbGpPWpGaD
Diflunisal—TTR—Disease—CD4—Crohn's disease	4.46e-06	0.000839	CbGpPWpGaD
Diflunisal—TTR—Disease—PTGS2—Crohn's disease	4.43e-06	0.000833	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—FADS1—Crohn's disease	4.33e-06	0.000814	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	4.14e-06	0.000778	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC11A1—Crohn's disease	4.13e-06	0.000777	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GPX4—Crohn's disease	4.05e-06	0.000762	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.96e-06	0.000744	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GCKR—Crohn's disease	3.92e-06	0.000736	CbGpPWpGaD
Diflunisal—PTGS2—Disease—RBX1—Crohn's disease	3.54e-06	0.000666	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HSPA1B—Crohn's disease	3.54e-06	0.000666	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.52e-06	0.000662	CbGpPWpGaD
Diflunisal—ALB—Metabolism—FADS1—Crohn's disease	3.5e-06	0.000658	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TYK2—Crohn's disease	3.46e-06	0.000649	CbGpPWpGaD
Diflunisal—TTR—Disease—STAT3—Crohn's disease	3.46e-06	0.000649	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2RA—Crohn's disease	3.44e-06	0.000646	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—JAK2—Crohn's disease	3.3e-06	0.00062	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GPX4—Crohn's disease	3.28e-06	0.000616	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GCKR—Crohn's disease	3.17e-06	0.000595	CbGpPWpGaD
Diflunisal—PTGS2—Disease—UBE2D1—Crohn's disease	3.11e-06	0.000584	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.08e-06	0.000579	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL8—Crohn's disease	3.01e-06	0.000565	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.8e-06	0.000526	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STAT3—Crohn's disease	2.42e-06	0.000455	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6—Crohn's disease	2.41e-06	0.000454	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—JAK2—Crohn's disease	2.31e-06	0.000434	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SMAD3—Crohn's disease	2.22e-06	0.000418	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.98e-06	0.000372	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6—Crohn's disease	1.69e-06	0.000318	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALB—Crohn's disease	1.57e-06	0.000295	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TYK2—Crohn's disease	1.45e-06	0.000272	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JAK2—Crohn's disease	1.38e-06	0.00026	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTGS2—Crohn's disease	1.37e-06	0.000258	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD4—Crohn's disease	1.31e-06	0.000246	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALB—Crohn's disease	1.25e-06	0.000234	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT3—Crohn's disease	1.02e-06	0.000191	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—Crohn's disease	8.82e-07	0.000166	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6—Crohn's disease	7.09e-07	0.000133	CbGpPWpGaD
